Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Exam 3 > Biochemistry 3 > Flashcards

Biochemistry 3 Flashcards

1
Q

isoprenoids

A 
A class of lipids.
Ex: cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

long chain fatty acids

A

> 12 carbons.

Absorbed in small intestine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

medium chain fatty acids

A

6-12 carbons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

short chain fatty acids

A

<6 carbons.
Produced in colon by microbiome.
Can cross blood-brain barrier.
6-10% of total energy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Essential FAs

A

Linoleic Acid: omega 6, [18:2 delta 9,12]
Linolenic Acid: omega 3 [18:3 delta 9,12,15]

Deficiency: alopecia, scaly dermatitis, thrombocytopenia, cognitive development, dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TAGs (general properties)

A

3 FA chains.
Glycerol backbone.
Ester bond.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Leptin

A

Suppresses food intake.
Released by adipose.
Alters hormones released from hypothalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ghrelin

A

Increases food intake.

“Hunger hormone”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

digestion of lipids (before pancreas)

A

Mouth - lingual lipase.
Stomach - pancreatic lipase.

Both important for short/medium chain FA synthesis in neonates and those with pancreatic insufficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

digestion of lipids (after stomach)

A

Pancreas:
Pancreatic lipase - hydrolyzes esters 1 and 3, forming 2 FFA and 1 MAG.
Factor colipase: binds pancreatic lipase to keep it at the lipid-aqueous interface.
Cholesterol esterase: hydrolyzes cholesterol esters.
Phospholipase A2: removes 1 phospholipid FA.
Lysophospholipase: removes 2nd FA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bile salts

A

Cholesterol derivatives.
Made in liver.
Secreted from gall bladder.
Conjugated with glycine/taurine (negative charge).
Release controlled by CCK.
80-95% recycled via enterohepatic circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

gall stones caused by

A

imbalance of cholesterol, bile, and phospholipid secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pancreatitis

A

300,000 hospital admissions per year.
Elevated serum lipase and amylase.
Nausea, vomiting, pain, steatorrhea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

elevated bile salts

A

Causes pruritis.

Treatment: ursodeoxycholic acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

entry of digested lipids into enterocytes

A

Micelles bring cholesterol, FFA, and MAG to the enterocyte membrane (short/med FFA don’t need micelle).
Mainly enter via passive diffusion.
Cholesterol enters via NPC1 L1 transporter (receptor mediated).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dietary cholesterol enters the enterocyte via

A

NPC1 L1 transporter (receptor mediated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

export out of enterocytes

A

FFAs must be converted to CoA derivatives.
CoA derivatives + MAG = TAG (via TAG synthase).
Cholesterol converted to a cholesterol ester (via ACAT).
Chylomicrons form and are released into lacteal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

chylomicron formation

A

Formed between lipid bilayer of ER membrane, then buds.
ApoB48 is added (now a nascent chylomicron).
MTP (microsomal TAG transfer protein) loads with TAGs and other lipids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

chylomicron release

A

Nascent chylomicrons transported from ER to Golgi.
Vesicles from golgi fuse with plasma membrane and release into the lacteal.
Enter lymphatic system.
ApoC-II and ApoE transferred from HDL (now a mature chylomicron).
Enter blood through thoracic duct, subclavian vein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

chylomicron degradation

A

Lipoprotein lipase activated by ApoC-II.
Adipose absorb resulting FAs and MAGs (passive).
ApoE and ApoB48 bind LRP, allowing chylomicron remnants to be internalized by the liver.
Endocytosis/degradation by liver.
Cholesterol esterase releases free cholesterol from cholesterol esters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LPL isozymes

A

Muscle LPL has a much higher affinity (lower Km) than adipose LPL.

Muscle needs energy basically all the time.
Adipose only needs FAs for storage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Bassen-Kornzweig Disease/ Abetalipoproteinemia

A 
Genetic defect of MTP.
Low TAG/cholesterol levels.
Steatorrhea, abdominal distension.
Clumsiness, progressive ataxia, neuropathy, vision impairment.
High levels of acanthocytes (>50%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Familial chylomicronemia syndrome

A

No LPL –> cannot release FAs from chylomicrons.
Severe hypertriglyceridemia.
Pancreatitis.
Xanthoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

VLDL

A

Synthesized in liver.
TAGs and CEs added via TAG synthase and ACAT.
ApoB100 is a characteristic lipoprotein.
Exported in blood to adipose and other tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

VLDL hydrolysis

A

Via LPL (lipoprotein lipase).
Stimulated by ApoC-II.
LPL is on capillary walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

IDL

A

When CE = TAGs.
ApoC-II falls off.
HTGL (Hepatocyte Triacylglycerol Lipase) removes remaining TAGs –> becomes LDL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

LDL

A

Major transporter of cholesterol to tissues.
Longest half-life.
Can get oxidized if it circulates for too long (contributes to atherosclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

LDL oxidation

A

Oxidized LDL stimulates monocyte recruitment to blood vessel wall.
Monocytes differentiate into macrophages, and engulf ox-LDL, become foam cells, then die.
Atherosclerotic plaque forms (fatty streak is dead foam cells, smooth muscle growth, matrix degradation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

HDL lifecycle

A

“Good cholesterol”.
Synthesized in liver.
Empty shell of phospholipids.
Characteristic lipoproteins: ApoA-I and ApoA-II.
ApoC and ApoE also present, and passed to chylomicrons/VLDL in the blood.
ApoAI stimulates LCAT: removes a FA from membrane to form CE from excess cholesterol that cells moved to their surface; produces lysolecithin.
Full HDLs are bound by SR-B1 receptors on liver, adrenals, for degradation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

CHD risk factors (and effect on HDL/LDL)

A

Smoking decreases HDL.
Diabetes/obesity increases LDL.
Lack of exercise increases LDL, decreases HDL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Familial Hypercholesterolemia

A

Type of hyperlipoproteinemia.
Defective LDL receptor.
LDL stays in blood, gets oxidized.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

release of FAs stored in adipose

A

Glucagon and epinephrine activate cAMP-dependent protein kinase –> phosphorylates HSL –> hydrolyzes adipose TAGs to FAs.

FFAs transported on serum albumin.
Passively transported into cells for oxidation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

prep for FA catabolism

A

Fatty acyl CoA synthetase activates FFA–> acyl CoA.

Activated long chain FAs need carnitine transporter to get into mitochondrial matrix.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Carnitine Transporter

A

Long chain FAs added to carnitine via CPT1.
Fatty acylcarnitine is transferred into the mitochondrial matrix via carnitine:acylcarnitine translocase, in exchange for 1 carnitine exiting mito matrix.
CPT2 converts acylcarnitine to acyl-CoA in matrix.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

regulation of carnitine transporter

A

CPT1 inhibited by MCoA (1st step of FA synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

FA oxidation

A

Occurs on B-carbon.

1) Acyl CoA DH: forms 2,3-trans-enoyl CoA, produces FADH2
2) 2-3 Enoyl CoA Hydratase: Forms 3-hydroxyacyl CoA, requires water.
3) 3-OH-acylCoA DH: Forms 3-keto fatty acyl CoA, produces NADH.
4) 3-ketoacylCoA thiolase: Forms fatty acyl CoA + acetyl CoA
5) REPEAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

net reaction of 1 cycle of FA oxidiation

A 
1 FADH2
3 NADH
1 GTP
=
12 ATP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

fatty acyl CoA DH isozymes

A 
1st step of B-oxidation.
VLCAD: 14-20 carbons
LCAD: 12-18 carbons (palitate, stearate)
MCAD: 6-12 carbons
SCAD: <6 carbons
39
Q

unsaturated FA (extra steps in B-ox)

A

2,4 Dienoyl CoA Reductase: reduces 1 double bond, requires NADPH.
Enoyl CoA isomerase: rearranges double bond so B-ox can continue.

40
Q

branched chain FAs

A

Phytanic acid, derived from plants.
Alpha-oxidation, thiolase, beta-oxidation, thiolase.
Produces propionyl CoA.

41
Q

Refsum Disease

A

Genetic deficiency in alpha-oxidation (branched chain FAs).

Neurological disorder.

42
Q

location of FA synthesis

A

cytosol

43
Q

location of FA degradation

A

mitochondria

44
Q

citrate shuttle

A

Citrate (from TCA) can exit mitochondria into cytosol.
In cytosol, can regenerate ACoA + oxaloacetate.
ACoA is then used for FA synthesis;
Oxaloacetate –> malate –> pyruvate.
Pyruvate enters mitochondria and repeats.
Produces NADPH.

45
Q

preparation of ACoA for FA synthesis

A

ACoA –> MCoA
By enzyme ACC (acetyl CoA carboxylase).
Biotin dependent.
Requires ATP.

46
Q

global regulation of ACC

A

ACC catalyses ACoA –> MCoA.

Epinephrine/glucagon activate PKA –> inhibits PP2A –> ACC remains inactive/phosphorylated.
Epinephrine/glucagon activate AMPK –> inactivates/phosphorylates ACC.

Insulin activates PP2A –> ACC becomes dephosphorylated/active

47
Q

local regulation of ACC

A

Citrate (substrate) activates ACC into polymer form.

Absence of citrate deactivates ACC (monomer form).

48
Q

FA Synthase (FAS)

A

Multiple enzymes in a single polypeptide.
Domain 1: substrate entry, condensation.
Domain 2: reduction.
Domain 3: palmitate release.

49
Q

FA synthesis: situating substrates on enzyme

A

ACoA binds to CE (condensince enzyme) via ACoA Acetyltransferase.
MCoA covalently binds to ACP (Acl carrier protein) via MCoA-ACP Transacetylase.
ACP has phosphopantetheinyl group: flexible arm that moves substrates to each domain.

50
Q

FA synthesis: reactions on enzyme

A

1) CONDENSATION:
Add MCoA to ACoA.
By CE (condensing enzyme) / 3-ketoacyl-ACP synthase.
Decarboxylates malonate, transferring 2 carbons to ACoA.
Releases CO2.
Forms acetyl-acetyl-ACP

2) REDUCTION
By B-ketoreductase / 3-ketoacyl-ACP reductase.
Uses NADPH.
Reduces ketone to hydroxyl.
Forms hydroxybutyryl-ACP.
3) DEHYDRATION
By dehydratase / 3-hydroxyacyl-ACP dehydratase.
Creates a double bond.
Releases water.
Forms Crotonyl-ACP.
4) REDUCTION
By Enoyl-ACP reductase.
Uses NADPH.
Reduces double bond.
Forms Butyryl-ACP

5) REPEAT

6) RELEASE PALMITATE
By thioesterase.
Requires water (hydrolysis).
*different thioesterase in mammary glands that releases C8-C14 FA which are more readily absorbable.

51
Q

Net reaction of FA synthesis

A

8 ACoA + 7 ATP + 14 NADPH + 14 H+ —> Palmitate + 8 CoA + 6 H2O + 7 ADP + 7 Pi

52
Q

general steps of FA synthesis (no enzymes/structures)

A 
Attach MCoA to ACP.
Attach ACoA to CE.
Condensation.
Reduction.
Dehydration.
Reduction.
Repeat.
Release palmitate.
53
Q

Step 1 of FA synthesis: condensation

A

1) CONDENSATION:
Add MCoA to ACoA.
By CE (condensing enzyme) / 3-ketoacyl-ACP synthase.
Decarboxylates malonate, transferring 2 carbons to ACoA.
Releases CO2.
Forms acetyl-acetyl-ACP

54
Q

Step 2 of FA synthesis: reduction

A 
2) REDUCTION
By B-ketoreductase / 3-ketoacyl-ACP reductase.
Uses NADPH.
Reduces ketone to hydroxyl.
Forms hydroxybutyryl-ACP.
55
Q

Step 3 of FA synthesis: dehydration

A 
3) DEHYDRATION
By dehydratase / 3-hydroxyacyl-ACP dehydratase.
Creates a double bond.
Releases water.
Forms Crotonyl-ACP.
56
Q

Step 4 of FA synthesis: reduction

A 
4) REDUCTION
By Enoyl-ACP reductase.
Uses NADPH.
Reduces double bond.
Forms Butyryl-ACP
57
Q

release of palmitate after FA synthesis

A

RELEASE PALMITATE
By thioesterase.
Requires water (hydrolysis).
*different thioesterase in mammary glands that releases C8-C14 FA which are more readily absorbable.

58
Q

elongation of FA

A

In smooth ER (sometimes in mitochondria).
Same steps as FA synthesis, but different enzymes.
Acyl chain carrier is CoA instead of ACP.
Elongates in units of 2 at carboxyl end.

59
Q

desaturation of FAs

A

In smooth ER.
4 types of human desaturases: delta 4, 5, 6, 9.
Cannot desaturate past C9 –> linoleic and linolenic acids are essential.
By mixed function oxidases.
NADH, cytochrome b5, O2.

60
Q

Modification of MUFA to PUFA

A

Add additional double bond.

By Fatty Acyl CoA Desaturase.

61
Q

source of NADPH

A

ACoA synthesis from citrate shuttle (8 NADPH).

Pentose Phosphate Pathway (6 NADPH).

62
Q

TAGs (general info)

A 
3 FAs + glycerol backbone.
Ester bonds.
Position 1: saturated
Position 2: unsaturated
Position 3: either (usually saturated).

Is major storage in cytosol of adipocytes.

63
Q

source of glycerol backbone for TAGs

A

1) glycerol from breakdown of TAGs
2) DHAP from glycolysis

Enzyme needed for option 1 is not present in adipocytes.
Adipocytes must use DHAP in adipose.

64
Q

TAG synthesis

A

1) DHAP –> glycerol-phosphate
By glycerol-3-phosphate DH.

2) add FAs 1 and 2
By Acyl transferase.
Must first be activated by Acyl CoA synthetase.

3) get rid of the phosphate on the 3 position.
By phosphatidic acid phosphatase.
Requires water.
Forms a diacylglycerol.

4) add 3rd FA
By acyl transferase / diacylglycerol transferase (DGAT).
Must first be prepped by Acyl CoA synthetase.
Now have a complete TAG

DGAT is committed step

65
Q

ketone bodies

A 
Alternative fuel source.
Form after days of fasting, or in diabetics.
Water soluble.
Cross BBB.
Not used in liver.
66
Q

3 forms of ketone bodies

A

acetone
acetoacetate
hydroxybutyric acid

67
Q

location of ketone body synthesis

A

Mitochondria of liver.

68
Q

why do ketone bodies form?

A

Excess of FAs delivered to liver.
More ACoA than liver needs is formed.
Converts excess ACoA into ketone bodies for export.

69
Q

synthesis of ketone bodies

A

1) Condensation of 2 ACoAs
By tholase.
Forms Acetoacyl CoA.

2) Add another ACoA.
By HMG-CoA reductase.
Requires water.
Forms HMG-CoA.

3) Release 1 CoA.
By HMG-CoA lyase.
Forms acetoacetate.

*) Can make acetone from acetoacetate.
By acetoacetate decarboxylase.
Releases CO2.

*) Can make D-B-hydroxybutyrate from acetoacetate.
By hydroxybutyrate DH.
Uses NADH.

70
Q

degradation of ketone bodies

A

In extrahepatic tissues.

1) Oxidation of hydroxyl to carbonyl.
Hydroxybutyrate –> acetoacetate.
Produces NADH.

2) Add CoA.
From succinyl-CoA (TCA cycle).
By ketoacyl-CoA transferase.

3) Add another CoA.
From CoA-SH.
By thiolase.
Forms 2 ACoA.

ACoA enters TCA cycle.

71
Q

ketone bodies and uncontrolled diabetes

A

Ketone bodies can accumulate to high levels.
KBs are buffered with cations in blood (KBs are negatively charged).
When excreted, cations are excreted too.
With less cations, buffering ability of blood is reduced.
Ketoacidosis results.
Can be severe/fatal.

72
Q

medical uses of ketogenic diets

A

PDH deficiency.
Epilepsy.
Type II DM : keeps glucose at a lower level; eliminates spikes in blood sugar, reducing need for insulin.

73
Q

three major classes of membrane lipids

A

1) Glycerophospholipids (GPLs)
2) Phosphosphingolipids
3) Sphingolipids/glycolipids

74
Q

glycerophospholipids (general)

A

Position 1: saturated FA
Position 2: unsaturated FA
Head alcohol group linked by phosphodiester bond.
Scaffold: glycerol.
Head groups: ethanolamine (E), choline (C), serine (S), glycerol (G), inositol (I)

In specific cases, di-saturated FAs are present to increase membrane fluidity (in lung alveoli).

75
Q

phosphospingolipids (general)

A

Scaffold: sphingosine (1 built in FA)
Position 2: fatty acid
Head group alcohol linked by phosphodiester bond.
FA attached via AMIDE bond.
Important in brain, common membrane component.

76
Q

sphingolipids/glycolipids

A

Scaffold: sphingosine (1 built in FA)
Position 2: FA
Head group: sugar (glucose/galactose).
FA attached via AMIDE bond.

77
Q

major intermediateds/sources of GPL scaffold

A

GPL scaffold: glycerol

1) phosphatidic acid: from G3P in glycolysis.
2) DAG: from dietary fat

78
Q

Phosphodiester Bond Formation on GPL

A

First the phosphate group (of either the head or scaffold, depending) is activated by linking CMP (cytidine monophosphate) to generate CDP (cytidine monophosphate).

If the DAG is activated with CDP, then head group hydroxyl can attack phosphate and bind (For PI, PG, Cardiolipin)
If head group is activated with CDP, then the hydroxyl on the scaffold can attack to make the bond (PE, PC)

When the hydroxyl attacks, it displaces CMP, forming the phosphodiester linkage.

79
Q

Interconversion between Glycerophospholipids

A

PC: DAG + CDP choline or PE + 3xSAM methylation

PE: DAG + CDP ethanolamine or PS + decarboxylation of serine

PS: PE + exchange serine for ethanolamine

80
Q

Phospholipases (PLs)

A

PLA1 cut off the FA from position 1.
PLA2 cut off FA from position 2.
PLCs cut to give DAG + the phosphorylated head group alcohol (decapitate).
PLDs give phosphatidic acid (DAG with a phosphate on C3) + the head group alcohol (decapitate, but leave phosphate).

81
Q

PLA1/2

A

Cut off the FA from position 1 and 2, respectively.
PLAs can rearrange FAs.
PLAs are in many venoms.

Lysophospholipids (missing 1 FA) act as hemolytic detergents.

82
Q

PLC

A

Cut to give DAG + the phosphorylated head group alcohol (decapitate).
Gives DAG + IP3 (signaling molecules)

83
Q

PLD

A

Give phosphatidic acid (DAG with a phosphate on C3) + the head group alcohol (decapitate, but leave phosphate)

84
Q

cyclooxygenases

A

Cyclooxygenase adds 2x O2 to PUFAs, causing loss of 2 double bonds)
Forms prostaglandins and thromboxanes.
Inhibited by aspirin and anti-inflammatory drugs.

85
Q

prostaglandins and thromboxanes

A

Mediate pain sensation, inflammation, fever, thrombosis.

86
Q

leukotrienes

A

Immune response signalling molecules.
Formed when PLA2-released PUFAs are acted upon by lipoxygenases.
Add just 1 O2, do NOT change # of double bonds.

Cellular chemotaxis, cytokine release, mediate vascular permeability/bronchocontriction.

87
Q

DAG

A

Formed by cleavage of PIP2 by PLC (forms DAG and IP3).

Activates protein kinase C.

88
Q

IP3

A 
Formed by cleavage of PIP2  by PLC (forms DAG and IP3).
In cytoplasm.
Causes release of Ca++ from ER stores.
Activates calmodulin kinase.
Helps activate PKCs.
89
Q

PLC cleavage of PIP2

A

Activated by G protein when peptide hormone binds to a membrane-spanning receptor.
Forms DAG and IP3.
Products are second messengers that allow the signal to be amplified inside the cell

90
Q

Ceramide formed by

A

addition of 1 FA to sphingosine (through amide bond)

91
Q

sphingomyelin formed by

A

addition of phosphodiester-linked choline to ceramide.

Myelin sheath component

92
Q

galactocerebroside formed by

A

Addition of galactose to ceramide

93
Q

Tay-Sachs disease

A

Defect in hexosamidase A.

Normally cuts a sugar off of ganglioside GM2 to generate GM3

94
Q

cholesterol synthesis

A

Substrates: cytoplasmic ACoA and NADPH (same as FA synthesis).
HMG-CoA synthase makes HMG-CoA in cytoplasm.
HMG-CoA reductase reduces HMG-CoA to mevalonate (uses NADPH)–COMMITTED STEP.
Mevalonate converted

Exam 3 (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions